Aquatic Capital Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-8,956
Closed -$63.3K – 1406
2024
Q4
$63.3K Buy
+8,956
New +$71.3K ﹤0.01% 1138
2023
Q4
– Sell
-7,200
Closed -$73K – 1450
2023
Q3
$73K Buy
+7,200
New +$86K ﹤0.01% 890
2023
Q2
– Sell
-3,400
Closed -$40K – 1502
2023
Q1
$40K Buy
+3,400
New +$43.3K ﹤0.01% 927
2022
Q2
– Sell
-700
Closed -$18K – 1352
2022
Q1
$18K Sell
700
-1,300
-65% -$36.9K 0.03% 519
2021
Q4
$79K Buy
+2,000
New +$91.1K 0.15% 176

Other funds holding HCAT

Aquatic Capital Management's HCAT Position: Q1 2025 in Review

Aquatic Capital Management sold out of Health Catalyst (HCAT) in Q1 2025, closing a stake of 8,956 shares — an estimated $63.3K sold.

Aquatic Capital Management first reported a position in HCAT in Q4 2021 and held it in 5 quarters. The position peaked at $79K in Q4 2021. 165 funds tracked by Wall St. Rank hold HCAT as of Q1 2025.

  • Aquatic Capital Management reported no remaining Health Catalyst position as of Q1 2025 after selling out during the quarter.
  • Aquatic Capital Management sold 8,956 Health Catalyst shares in Q1 2025, an estimated $63.3K.
  • Aquatic Capital Management first reported a position in Health Catalyst in Q4 2021 and held it in 5 quarters.
  • Aquatic Capital Management's Health Catalyst position peaked at $79K in Q4 2021.
  • 165 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2025.

Based on Aquatic Capital Management's 13F filing for Q1 2025, filed 15 May 2025.